Amino Acid Profiles in the Biological Fluids and Tumor Tissue of CRC Patients

被引:3
作者
Santos, Marisa Domingues [1 ,2 ,3 ]
Barros, Ivo [2 ]
Brandao, Pedro [1 ,2 ,3 ]
Lacerda, Lucia [2 ,3 ,4 ]
机构
[1] Ctr Hosp Univ Santo Antonio, Hosp Santo Antonio, Colorectal Unit, P-4050651 Porto, Portugal
[2] Univ Porto, ICBAS Sch Med & Biomed Sci, UMIB Unit Multidisciplinary Res Biomed, P-4050313 Porto, Portugal
[3] ITR Lab Integrat & Translat Res Populat Hlth, P-4050313 Porto, Portugal
[4] Ctr Hosp Univ Santo Antonio, Ctr Genet Med Jacinto de Magalhaes, Genet Lab Serv, P-4050651 Porto, Portugal
关键词
colorectal cancer; biomarkers; amino acids; metabolomics; diagnosis; prognosis; treatment response; laboratorial findings; HUMAN COLORECTAL-CANCER; METABOLOMICS APPROACH; NEOADJUVANT CHEMOTHERAPY; BIOMARKERS; SIGNATURE; IDENTIFY; GLYCINE; PATHWAY; CELLS;
D O I
10.3390/cancers16010069
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Amino acids are the fundamental building blocks of proteins and play a crucial role in various cellular functions, such as protein metabolism/catabolism pathways and redox signaling. They are also vital in normal and cancer metabolism. The concentrations of amino acids in blood, urine, and tissue samples of cancer patients differ from those of healthy individuals. These differences can be used for cancer screening, monitoring treatment response, and predicting tumor prognosis. Colorectal cancer (CRC) is one of the most common and deadly cancers. This review aims to gather reported amino acid abnormalities in blood, urine, and tissue samples of CRC patients and how these abnormalities can be used as potential tools in the multifold management of CRC, including screening, establishing cancer prognosis, and monitoring treatment response.Abstract Amino acids are the building blocks of proteins and essential players in pathways such as the citric acid and urea cycle, purine and pyrimidine biosynthesis, and redox cell signaling. Therefore, it is unsurprising that these molecules have a significant role in cancer metabolism and its metabolic plasticity. As one of the most prevalent malign diseases, colorectal cancer needs biomarkers for its early detection, prognostic, and prediction of response to therapy. However, the available biomarkers for this disease must be more powerful and present several drawbacks, such as high costs and complex laboratory procedures. Metabolomics has gathered substantial attention in the past two decades as a screening platform to study new metabolites, partly due to the development of techniques, such as mass spectrometry or liquid chromatography, which have become standard practice in diagnostic procedures for other diseases. Extensive metabolomic studies have been performed in colorectal cancer (CRC) patients in the past years, and several exciting results concerning amino acid metabolism have been found. This review aims to gather and present findings concerning alterations in the amino acid plasma pool of colorectal cancer patients.
引用
收藏
页数:15
相关论文
共 79 条
  • [1] Circulating Cell-Free DNA: A Promising Marker of Pathologic Tumor Response in Rectal Cancer Patients Receiving Preoperative Chemoradiotherapy
    Agostini, Marco
    Pucciarelli, Salvatore
    Enzo, Maria Vittoria
    Del Bianco, Paola
    Briarava, Marta
    Bedin, Chiara
    Maretto, Isacco
    Friso, Maria Luisa
    Lonardi, Sara
    Mescoli, Claudia
    Toppan, Paola
    Urso, Emanuele
    Nitti, Donato
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (09) : 2461 - 2468
  • [2] Branched-chain amino acid metabolism in cancer
    Ananieva, Elitsa A.
    Wilkinson, Adam C.
    [J]. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2018, 21 (01) : 64 - 70
  • [3] A gas chromatography-mass spectrometry (GC-MS) metabolomic approach in human colorectal cancer (CRC): the emerging role of monosaccharides and amino acids
    Barberini, Luigi
    Restivo, Angelo
    Noto, Antonio
    Deidda, Simona
    Fattuoni, Claudia
    Fanos, Vassilios
    Saba, Luca
    Zorcolo, Luigi
    Mussap, Michele
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (23)
  • [4] Circulating Biomarkers for Response Prediction of Rectal Cancer to Neoadjuvant Chemoradiotherapy
    Bedin, Chiara
    Crotti, Sara
    D'Angelo, Edoardo
    D'Aronco, Sara
    Pucciarelli, Salvatore
    Agostini, Marco
    [J]. CURRENT MEDICINAL CHEMISTRY, 2020, 27 (25) : 4274 - 4294
  • [5] Metabolomic NMR Fingerprinting to Identify and Predict Survival of Patients with Metastatic Colorectal Cancer
    Bertini, Ivano
    Cacciatore, Stefano
    Jensen, Benny V.
    Schou, Jakob V.
    Johansen, Julia S.
    Kruhoffer, Mogens
    Luchinat, Claudio
    Nielsen, Dorte L.
    Turano, Paola
    [J]. CANCER RESEARCH, 2012, 72 (01) : 356 - 364
  • [6] Colorectal Cancer and Metabolism
    Brown, Rachel E.
    Short, Sarah P.
    Williams, Christopher S.
    [J]. CURRENT COLORECTAL CANCER REPORTS, 2018, 14 (06) : 226 - 241
  • [7] Prognostic Role of Serum Amino Acids in Head and Neck Cancer
    Cadoni, Gabriella
    Giraldi, Luca
    Chiarla, Carlo
    Gervasoni, Jacopo
    Persichilli, Silvia
    Primiano, Aniello
    Settimi, Stefano
    Galli, Jacopo
    Paludetti, Gaetano
    Arzani, Dario
    Boccia, Stefania
    Giovannini, Ivo
    Almadori, Giovanni
    [J]. DISEASE MARKERS, 2020, 2020
  • [8] Metabolic Profiling of Human Colorectal Cancer Using High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance (HR-MAS NMR) Spectroscopy and Gas Chromatography Mass Spectrometry (GC/MS)
    Chan, Eric Chun Yong
    Koh, Poh Koon
    Mal, Mainak
    Cheah, Peh Yean
    Eu, Kong Weng
    Backshall, Alexandra
    Cavill, Rachel
    Nicholson, Jeremy K.
    Keun, Hector C.
    [J]. JOURNAL OF PROTEOME RESEARCH, 2009, 8 (01) : 352 - 361
  • [9] Immunohistochemical Study of the Nrf2 Pathway in Colorectal Cancer: Nrf2 Expression is Closely Correlated to Keap1 in the Tumor and Bach1 in the Normal Tissue
    Chang, Liang-Che
    Fan, Chung-Wei
    Tseng, Wen-Ko
    Chen, Jim-Ray
    Chein, Hui-Ping
    Hwang, Cheng-Cheng
    Hua, Chung-Ching
    [J]. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2013, 21 (06) : 511 - 517
  • [10] Tryptophan Catabolism and Response to Therapy in Locally Advanced Rectal Cancer (LARC) Patients
    Crotti, Sara
    Fraccaro, Alessandra
    Bedin, Chiara
    Bertazzo, Antonella
    Di Marco, Valerio
    Pucciarelli, Salvatore
    Agostini, Marco
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10